Vanguard Group’s Livongo Health, Inc. Common Stock LVGO Stock Holding History

Vanguard Group’s Portfolio LVGO Stock Details LVGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,237,681	Closed	-$734M	–	4251
2020 Q3	$734M	Buy	5,237,681 +1,027,282	+24%	+$125M	0.02%	623
2020 Q2	$317M	Buy	4,210,399 +2,120,427	+101%	+$111M	0.01%	993
2020 Q1	$59.6M	Buy	2,089,972 +205,531	+11%	+$5.32M	﹤0.01%	1784
2019 Q4	$47.2M	Buy	1,884,441 +723,083	+62%	+$17.3M	﹤0.01%	2135
2019 Q3	$20.3M	Buy	+1,161,358	New	+$35.1M	﹤0.01%	2489

Vanguard Group's LVGO Position: Q4 2020 in Review

Vanguard Group sold out of Livongo Health, Inc. Common Stock (LVGO) in Q4 2020, closing a stake of 5,237,681 shares — an estimated $734M sold.

Vanguard Group first reported a position in LVGO in Q3 2019 and held it in 5 quarters. The position peaked at $734M in Q3 2020. 0 funds tracked by Wall St. Rank hold LVGO as of Q4 2020.

Vanguard Group reported no remaining Livongo Health, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Vanguard Group sold 5,237,681 Livongo Health, Inc. Common Stock shares in Q4 2020, an estimated $734M.
Vanguard Group first reported a position in Livongo Health, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Vanguard Group's Livongo Health, Inc. Common Stock position peaked at $734M in Q3 2020.
0 funds tracked by Wall St. Rank held Livongo Health, Inc. Common Stock as of Q4 2020.

Based on Vanguard Group's 13F filing for Q4 2020, filed 12 Feb 2021.